Suppr超能文献

转移性腺管型胰腺腺癌原发部位(头部、体部和尾部)与肿瘤学结局的关系:基于人群的分析。

Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis.

机构信息

Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands.

Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.

出版信息

Eur J Cancer. 2019 Jan;106:99-105. doi: 10.1016/j.ejca.2018.10.008. Epub 2018 Nov 23.

Abstract

INTRODUCTION

The relation between the primary origin of metastasised pancreatic ductal adenocarcinoma (PDAC)-head, body or tail-metastatic patterns and outcomes has not yet been investigated in large population-based studies.

METHODS

Patients with metastasised PDAC at diagnosis from the Netherlands Cancer Registry were included (2005-2015). We compared number of metastatic organ sites (1, 2, ≥3) and specific metastatic organ sites (peritoneum, liver, lung and extra-regional lymph nodes) for the different primary tumour locations. Cox regression analyses were used to determine the association of tumour location and metastatic organ site(s) with overall survival.

RESULTS

Overall, we included 9952 patients with metastasised PDAC. The primary origin was head in 5644 (57%), body in 1671 (17%) and tail in 2637 (26%) patients. Differences between primary origins were the number of metastatic organ sites (proportions ≥3 sites for head: 4%, for body: 8% and for tail: 13%, p < 0.0001) and peritoneal metastases (present in 13% for head, 24% for body and 30% for tail; p < 0.0001). Median overall survival was 2.6 months for head PDAC (reference), 2.4 months for body PDAC (HR 1.02 [0.97-1.08]) and 1.9 months for tail PDAC (HR 1.20 [1.15-1.26]). Of patients with one metastatic organ site, the worst survival compared with other sites was seen with liver only metastases (2.5 months vs. 2.7-5.1 months), and the best survival for patients, with extra-regional lymph node only metastases (5.1 months).

CONCLUSION

Metastatic patterns differ among the primary origins for PDAC with metastasised tail tumours having more metastatic sites, more often peritoneal metastases and worse survival.

摘要

简介

原发于胰腺导管腺癌(PDAC)头部、体部或尾部的转移癌的转移模式和结局之间的关系尚未在大型基于人群的研究中进行研究。

方法

从荷兰癌症登记处纳入诊断为转移性 PDAC 的患者(2005-2015 年)。我们比较了不同原发肿瘤部位的转移性器官部位(1、2、≥3 个)和特定转移性器官部位(腹膜、肝脏、肺部和区域外淋巴结)的数量。使用 Cox 回归分析来确定肿瘤部位和转移性器官部位与总生存的关联。

结果

总体而言,我们纳入了 9952 例转移性 PDAC 患者。原发部位为头部的有 5644 例(57%),体部的有 1671 例(17%),尾部的有 2637 例(26%)。原发部位之间的差异在于转移性器官部位的数量(部位≥3 个的比例:头部为 4%,体部为 8%,尾部为 13%,p<0.0001)和腹膜转移(头部为 13%,体部为 24%,尾部为 30%;p<0.0001)。头部 PDAC 的中位总生存期为 2.6 个月(参考),体部 PDAC 为 2.4 个月(HR 1.02 [0.97-1.08]),尾部 PDAC 为 1.9 个月(HR 1.20 [1.15-1.26])。在仅有一个转移器官部位的患者中,与其他部位相比,仅肝脏转移的患者生存最差(2.5 个月比 2.7-5.1 个月),而仅区域外淋巴结转移的患者生存最佳(5.1 个月)。

结论

转移性 PDAC 的转移模式在原发部位之间存在差异,尾部肿瘤转移部位更多,腹膜转移更常见,生存更差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验